Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Ayurveda firm Kapiva...

    Ayurveda firm Kapiva to raise 8 million dollars

    Written by Ruby Khatun Khatun Published On 2017-11-09T09:37:46+05:30  |  Updated On 18 Aug 2021 3:05 PM IST

    A healthcare startup Kapiva Ayurveda is planning to raise about $8 million within a year-and-half to expand its product portfolio and invest in marketing, a recent report in The Hindu states.


    Kapiva Ayurveda is a disruptive healthcare start-up in the fast-growing global Ayurveda market. Backed by the iconic Baidyanath Group, Kapiva focuses on adapting traditional Ayurvedic knowledge to the needs of the modern consumer.

    Ameve Sharma, president, Kapiva Ayurveda told The Hindu "Kapiva raised one million dollars about 10 months ago from Gits Foods and other private investors. The Baidyanath family also invested in the venture. Now we have to spend money on marketing and that is a big spend. We are looking at PE investors or venture capitalists for the next round of funding."


    Kapiva faces competition from brands such as Dabur, Himalaya and new entrant Patanjali. The company also exports its products in U.S. market with 50% sales. The company sells herbal capsules, juices, and oils through its own stores and offers a range of more than 200 products for a variety of ailments.

    "The target audience for our products is the ones in the age group of between 35 and 45. We use the manufacturing facilities and research and development centers of Baidyanath. Our aim is to arrive at the right sourcing and dosage which is vital if customers are taking our capsules," Mr. Sharma said to The Hindu.


    "The market for herbal supplements in the U.S. is huge and we will soon export our products to U.K., Germany, Australia and the Middle East." Kapiva plans to enter the personal care and grooming segment soon, he added.


    He further told The Hindu, "So far our products have been accepted by our customers due to word of mouth. The plan now is to make it available in more cities. During the last 10 months, we have had a total turnover of Rs 40 lakhs."


    "By end of this fiscal year we hope to reach one crore in terms of sales," he said.


    "We not only meet the standards laid down by AYUSH but we are also FDA compliant," Mr. Sharma said. "All the products also comply with the World Health Organization's GMP standards."

    AyushBaidyanathDaburfundFund raisefund raisingHealthcarehealthcare startupHimalayaInvestmentKapivaKapiva AyurvedamarketingPatanjaliWorld Health Organization
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok